Abstract:The aim of this study is to assess the prevalence and predictors of depressive symptoms in women with polycystic ovary syndrome (PCOS). In a cross-sectional study of 114 women seeking consultation for symptoms of PCOS (menstrual irregularity, hirsutism, and/or acne), personal and family history of depression (HD and FHD respectively) were enquired. Vitamin D status (n = 104) and manifest depressive symptoms assessed by personal health questionnaire (PHQ) (MD) were evaluated in a subset (85). Relationships betw… Show more
“…The phenomenon was related to Moran et al (2015), but there are some other available data that indicate comorbidity of depressive and anxiety disorders with sleep disorders in women with PCOS [8]. Sleep disorders, as it occurs, might be the one of predictors of depression in women suffering from PCOS [24]. Among examined patients an excessive daytime sleepiness was observed, what is also reported in available literature [22,18].…”
Sleep disturbances in women with Polycystic Ovary Syndrome (PCOS) have been reported in recent years. The majority of published studies are related to Obstructive Sleep Apnea (OSA) while not many researches have analyzed any other causes of sleep disturbances. A group of ninety five women with Polycystic Ovary Syndrome were enrolled into the study. Sleep disturbances were assessed using validated questionnaires. On the grounds of Athens Insomnia Scale (AIS) evaluation a clinically significant insomnia was ascertained in 12.6% of women with PCOS, while according to Insomnia Severity Index (ISI) in 10.5%. Clinically significant insomnia according to both AIS and ISI, occurred significantly more often in women with PCOS than in women without PCOS based on the chi-square test. The Mann-Whitney U test revealed statistically significant difference between women with and without PCOS based on total values of ISI. An excessive daytime sleepiness occurred at 7.4% of women with PCOS. Statistically significant dependance between: clinically significant insomnia in both AIS and ISI and excessive daytime sleepiness indicated by Epworth Sleepiness Scale (ESS) was observed. Sleep disorders are common in women with PCOS. Screening assessment of sleep disturbances should be a part of medical diagnostics in women with PCOS.
“…The phenomenon was related to Moran et al (2015), but there are some other available data that indicate comorbidity of depressive and anxiety disorders with sleep disorders in women with PCOS [8]. Sleep disorders, as it occurs, might be the one of predictors of depression in women suffering from PCOS [24]. Among examined patients an excessive daytime sleepiness was observed, what is also reported in available literature [22,18].…”
Sleep disturbances in women with Polycystic Ovary Syndrome (PCOS) have been reported in recent years. The majority of published studies are related to Obstructive Sleep Apnea (OSA) while not many researches have analyzed any other causes of sleep disturbances. A group of ninety five women with Polycystic Ovary Syndrome were enrolled into the study. Sleep disturbances were assessed using validated questionnaires. On the grounds of Athens Insomnia Scale (AIS) evaluation a clinically significant insomnia was ascertained in 12.6% of women with PCOS, while according to Insomnia Severity Index (ISI) in 10.5%. Clinically significant insomnia according to both AIS and ISI, occurred significantly more often in women with PCOS than in women without PCOS based on the chi-square test. The Mann-Whitney U test revealed statistically significant difference between women with and without PCOS based on total values of ISI. An excessive daytime sleepiness occurred at 7.4% of women with PCOS. Statistically significant dependance between: clinically significant insomnia in both AIS and ISI and excessive daytime sleepiness indicated by Epworth Sleepiness Scale (ESS) was observed. Sleep disorders are common in women with PCOS. Screening assessment of sleep disturbances should be a part of medical diagnostics in women with PCOS.
“…A previous meta-analysis highlighted that psychological distress is experienced by women affected by PCOS (Barry et al, 2011) and current studies demonstrate an increased prevalence of depressive symptoms and disorders (Legro et al, 2013). Women with PCOS are reported to experience depressive episodes approximately three times more frequently than healthy controls (HC) (Setji and Brown, 2014) and many explanations have been proposed for this relationship, such as negative body image associated with obesity, hirsutism, hyperandrogenism and acne, higher infertility rates and vitamin D deficiency (Stunkard et al, 2003;Weiner et al, 2004;Hollinrake et al, 2007;Adali et al, 2008;Kerchner et al, 2009;Bhattacharya and Jha, 2010;Jedel et al, 2010;Naqvi et al, 2015). All these factors could have an impact on depression in different ways in women with PCOS.…”
“…Women with PCOS may report clinically significant symptoms of anxiety or depression at least in part as a result of significant body changes imposed by their illness (eg, hirsutism, irregular menses, obesity, acne, hair thinning) 2,7. Previous research indicates that alterations in body image may contribute to psychological distress among women with PCOS 24…”
Section: Clinical and Research Implicationsmentioning
confidence: 99%
“…These symptoms can also contribute to psychological impairment 7. Despite the use of antidepressants in the treatment of depressive symptoms, there has been only one report to date on the use of serotonin reuptake inhibitors with a successful outcome in a patient with PCOS 8…”
BackgroundThe association between depression, anxiety, and polycystic ovary syndrome (PCOS) is still unclear. Therefore, a systematic review and meta-analysis was conducted to assess the rates of comorbid psychiatric disorders among women with PCOS compared to women without it.MethodsPubMed/MEDLINE, Embase, PsycINFO, and Web of Science databases were searched from inception to November 27, 2015. Studies were eligible for inclusion if they were original reports in which the rates of mood (bipolar disorder, dysthymia, or major depressive disorder), obsessive–compulsive spectrum disorders, trauma- and stressor-related disorders, anxiety disorders or psychotic disorders, somatic symptom and related disorders, or eating disorders had been investigated among women with an established diagnosis of PCOS and compared with women without PCOS. Psychiatric diagnosis should have been established by means of a structured diagnostic interview or through a validated screening tool. Data were extracted and pooled using random effects models.ResultsSix studies were included in the meta-analysis; of these, five reported the rates of anxiety and six provided data on the rates of depression. The rate of subjects with anxiety symptoms was higher in patients with PCOS compared to women without PCOS (odds ratio (OR) =2.76; 95% confidence interval (CI) 1.26 to 6.02; Log OR =1.013; P=0.011). The rate of subjects with depressive symptoms was higher in patients with PCOS compared to women without PCOS (OR =3.51; 95% CI 1.97 to 6.24; Log OR =1.255; P<0.001).ConclusionAnxiety and depression symptoms are more prevalent in patients with PCOS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.